




Crizotinib 250 mg capsules are a targeted cancer therapy designed to inhibit the growth of specific types of cancer cells. Primarily used for the treatment of non-small cell lung cancer (NSCLC) with ALK or ROS1 gene mutations, these capsules work by blocking the proteins that promote cancer cell proliferation. Suitable for adult patients, Crizotini

Crizotinib 250 mg capsules are a targeted cancer therapy designed to inhibit the growth of specific types of cancer cells. Primarily used for the treatment of non-small cell lung cancer (NSCLC) with ALK or ROS1 gene mutations, these capsules work by blocking the proteins that promote cancer cell proliferation. Suitable for adult patients, Crizotini








CRIZALK 250MG CAPSULE contains the active substance Crizotinib, a medicine used to treat adults with lung cancer called non-small cell lung cancer (NSCLC). It works by inhibiting a type of enzyme called tyrosine kinase and slowing down or stopping cancer cell growth.
250 Mg Crizotinib Capsules
